Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entity
Journal of Clinical & Translational Endocrinology · 2023-09 · 33 · 100322
DOI: 10.1016/j.jcte.2023.100322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical & Translational Endocrinology, 2023-09. Verfasst von Esther Osher und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Endocrinology, Metabolism, and Hypertension, Tel Aviv-Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Israel. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Pancreatic neuroendocrine tumors (PNETs) are rare, but their incidence has risen significantly in recent years. Whereas diabetes mellitus (DM) is recognized in association with chronic pancreatitis and pancreatic cancer, it has not been well-characterized concerning non-functioning (NF)-PNETs.Study aim: to determine whether NF-PNETs are associated with DM/ Pre-DM and characterize the features of this putative association.
Methods
Retrospective study to evaluate rate of Pre-DM /DM in subjects with NF-PNETs.
Results
Study cohort of 129 patients with histologically confirmed NF-PNETs, ∼60% were men (M/F: 77/52). Abnormal glucose metabolism that preceded any treatment was seen in 70% of this cohort: overt DM in 34% and Pre-DM in 36% of the subjects. However, during follow-up, the overall prevalence rose to 80.6%, owing exclusively to newly diagnosed DM in subjects who received treatment.Patients with DM/Pre-DM were older (65 ± 11; 54 ± 14; p < 0.0001), the tumor was more commonly localized in the pancreatic body and tail (76.5% vs. 23.5% p = 0.03), while BMI (27 ± 6 vs. 28 ± 5 kg/m2), and tumor size (2.4 ± 2 vs. 2.9 ± 3.2 cm) were similar. The relative prevalence of DM in our cohort of NF-PNETs was 1.6 higher than that in the age and gender-adjusted general Israeli population (95 %CI: 1.197-2.212p = 0.03).
Conclusions
We found a high rate of impaired glucose metabolism, either DM or Pre-DM, in a large cohort of NF-PNETs. The high prevalence of diabetes/pre-diabetes was unrelated to obesity or tumor size. This observation should increase awareness of the presence of DM on presentation or during treatment of "NF"-PNETs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Endocrinology, Metabolism, and Hypertension, Tel Aviv-Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
- Department of Oncology, Tel Aviv-Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
- Department of Surgery, Tel Aviv-Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
- Department of Gastroenterology, Tel Aviv-Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
- Institute of Pathology, Tel Aviv-Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
- Insitute of Radiology, Tel Aviv-Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
Zitieren
APA
Osher, E., Geva, R., Wolf, I., Tordjman, K., Klausner, J., Sofer, Y., Scapa, E., Shibolet, O., Ben-Ami Shor, D., Bar-Yishay, I., Lubezky, N., Goykhman, Y., Lahat, G., Yakir, O., Pelles, S., Aizic, A., Blachar, A., Stern, N., & Greenman, Y. (2023). Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entity. Journal of Clinical & Translational Endocrinology, 33, 100322. https://doi.org/10.1016/j.jcte.2023.100322
Vancouver
Osher E, Geva R, Wolf I, Tordjman K, Klausner J, Sofer Y, et al. Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entity. Journal of Clinical & Translational Endocrinology. 2023;33:100322. doi:10.1016/j.jcte.2023.100322
BibTeX
@article{Osher2023,
author = {Osher, Esther and Geva, Ravit and Wolf, Ido and Tordjman, Karen and Klausner, Joseph and Sofer, Yael and Scapa, Erez and Shibolet, Oren and Ben-Ami Shor, Dana and Bar-Yishay, Iddo and Lubezky, Nir and Goykhman, Yaacov and Lahat, Guy and Yakir, Oz and Pelles, Sharon and Aizic, Asaf and Blachar, Arye and Stern, Naftali and Greenman, Yona},
title = {Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entity},
journal = {Journal of Clinical & Translational Endocrinology},
year = {2023},
volume = {33},
pages = {100322},
doi = {10.1016/j.jcte.2023.100322}
}
EUVIMED